Increasing Regulatory Fairness Act of 2015
Do you support it?
Want to know if it passes?
We'll email you when HR 2507 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 2507.
You're tracking HR 2507
We'll email you the moment it moves.
HR 2507 — Increasing Regulatory Fairness Act of 2015
Last action — Received in the Senate and Read twice and referred to the Committee on Finance.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Increasing Regulatory Fairness Act of 2015 (Sec. 2) This bill amends part C (Medicare+Choice) of title XVIII (Medicare) of the Social Security Act to direct the Department of Health and Human Services, by regulation and in accordance with certain notice and public comment requirements, to determine and announce annually for 2017 and each subsequent year: the annual MedicareAdvantage (MA) capitation rate for each MA payment area for the year concerned, the risk and other factors to be used in adjusting such rates for monthly payments in such year, the MA region-specific non-drug monthly benchmark amount for each MA region and each MA regional plan for which a bid was submitted, and the major policy changes to the risk adjustment model and the 5-star rating system that are determined to have an economic impact.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 2507 on the official United States source →Action History
-
Received in the Senate and Read twice and referred to the Committee on Finance.
-
Motion to reconsider laid on the table Agreed to without objection.
-
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4481)
-
DEBATE - The House proceeded with forty minutes of debate on H.R. 2507.
-
Considered under suspension of the rules. (consideration: CR H4481-4483)
-
Mr. Brady (TX) moved to suspend the rules and pass the bill, as amended.
-
Placed on the Union Calendar, Calendar No. 115.
-
Committee on Energy and Commerce discharged.
-
Reported (Amended) by the Committee on Ways and Means. H. Rept. 114-159, Part I.
-
Referred to the Subcommittee on Health.
-
Ordered to be Reported (Amended) by Voice Vote.
-
Committee Consideration and Mark-up Session Held.
-
Referred to the Subcommittee on Health.
-
Referred to House Energy and Commerce
-
Referred to House Ways and Means
-
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Introduced in House
Sponsors
- Kevin Brady · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 2507 do?
- Increasing Regulatory Fairness Act of 2015 (Sec. 2) This bill amends part C (Medicare+Choice) of title XVIII (Medicare) of the Social Security Act to direct the Department of Health and Human Services, by regulation and in accordance with certain notice and public comment requirements, to determine and announce annually for 2017 and each subsequent year: the annual MedicareAdvantage (MA) capitation rate for each MA payment area for the year concerned, the risk and other factors to be used in adjusting such rates for monthly payments in such year, the MA region-specific non-drug monthly benchmark amount for each MA region and each MA regional plan for which a bid was submitted, and the major policy changes to the risk adjustment model and the 5-star rating system that are determined to have an economic impact.
- Who sponsors HR 2507?
- HR 2507 is sponsored by Kevin Brady (R).
- What is the current status of HR 2507?
- This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 2507?
- Track HR 2507 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 2507
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 2507
Last checked for changes about 10 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →